Independent information. England-wide.Public data. Clear sources.
comparelocalcareMake a more informed choice.

RESEARCH IN ENGLAND

Explore clinical trials with England locations

Search 2,970 registered studies with identifiable England locations in our dated ClinicalTrials.gov snapshot. Explore the study and local recruitment details before contacting the research team.

Clear filters

266 matching studies · ordered by study identifier.

The area filter uses exact source postcodes. Locations without a matched postcode remain in the England-wide results.

NCT00231400 · Observational

Pompe Disease Registry Protocol

Glycogen Storage Disease Type II · Pompe Disease

Study overall: Recruiting · source record updated 23 June 2026.

9 England locations · 9 explicitly recorded as recruiting.

NCT01633489 · Observational

Lysosomal Acid Lipase (LAL) Deficiency Registry

Lysosomal Acid Lipase Deficiency · Cholesterol Ester Storage Disease · Wolman Disease · Acid Cholesteryl Ester Hydrolase Deficiency, Type 2 · Acid Lipase Deficiency · LIPA Deficiency · LAL-Deficiency

Study overall: Recruiting · source record updated 6 March 2026.

5 England locations · 5 explicitly recorded as recruiting.

NCT01804686 · Interventional

A Long-term Extension Study of PCI-32765 (Ibrutinib)

Chronic Lymphocytic Leukemia · Small Lymphocytic Lymphoma · Mantle Cell Lymphoma · Follicular Lymphoma · Diffuse Large B-cell Lymphoma · Waldenstrom Macroglobulinemia · Chronic Graft Versus Host Disease

Study overall: Recruiting · source record updated 31 July 2026.

15 England locations · 2 explicitly recorded as recruiting.

NCT02445222 · Interventional

CAR-T Long Term Follow Up (LTFU) Study

Long Term Safety of Patients Receiving CAR-T in an Eligible Clinical Trial or Managed Access Program

Study overall: Recruiting · source record updated 28 October 2025.

2 England locations · 2 explicitly recorded as recruiting.

NCT03394365 · Interventional

A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy

Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD) · Solid Organ Transplant Complications · Lymphoproliferative Disorders · Allogeneic Hematopoietic Cell Transplant · Stem Cell Transplant Complications

Study overall: Recruiting · source record updated 2 September 2026.

3 England locations · 2 explicitly recorded as recruiting.

More ways to explore research

This is a selected international registry feed, not every study taking place in England. NIHR also lists participation opportunities, including studies that may not appear in this selection.

NIHR Be Part of ResearchSearch the original register

Source: ClinicalTrials.gov, a United States Government database. Contains OS data © Crown copyright and database right 2026. Contains National Statistics data © Crown copyright and database right 2024; ONS country boundaries (December 2024).

Source processed: 2026-09-10 09:00:04 UTC. Retrieved: 10 September 2026. ClinicalTrials.gov terms.

How we selected and connected these records

Selected registered studies with an overall status of Recruiting or Not yet recruiting and at least one England location established by postcode, recorded nation, or source coordinates within the ONS December 2024 boundary. Retained structured fields; omitted descriptions, eligibility text, contacts and non-England locations. Deduplicated identical locations. Linked local care areas only by exact postcode geography. Location points are used for nation filtering, not directions or facility matching.